Open Access. Powered by Scholars. Published by Universities.®
Digestive, Oral, and Skin Physiology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Bacteria (1)
- Biochemical Phenomena, Metabolism, and Nutrition (1)
- Chemical and Pharmacologic Phenomena (1)
- Chemicals and Drugs (1)
- Complex Mixtures (1)
-
- Gastroenterology (1)
- Laboratory Medicine (1)
- Medical Biochemistry (1)
- Medical Microbiology (1)
- Medical Pharmacology (1)
- Medicinal and Pharmaceutical Chemistry (1)
- Nephrology (1)
- Organisms (1)
- Other Chemicals and Drugs (1)
- Patient Safety (1)
- Pharmaceutical Preparations (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Public Health (1)
- Urology (1)
Articles 1 - 2 of 2
Full-Text Articles in Digestive, Oral, and Skin Physiology
Oral Dosages Of The Nsaid Aspirin Decreased The Growth Rate Of Species Found In The Human Gut Microbiome Including Akkermansia Muciniphila, Bacteroides Fragilis, Clostridium Sordellii, And Clostridium Difficile, Wyatt H. Greenbaum, Garrett J. Greenbaum, Anna Spiezio
Oral Dosages Of The Nsaid Aspirin Decreased The Growth Rate Of Species Found In The Human Gut Microbiome Including Akkermansia Muciniphila, Bacteroides Fragilis, Clostridium Sordellii, And Clostridium Difficile, Wyatt H. Greenbaum, Garrett J. Greenbaum, Anna Spiezio
PANDION: The Osprey Journal of Research and Ideas
Over past few decades, new insight has been revealed in the scientific community about the importance of the human gut microbiome relating to general health. It is known that imbalances in the species that reside in the human gut can cause organism-wide problems in humans. When prescribing or injecting oral medications, the thought of the downstream effects on the gut microbiome are not always considered. By exposing known healthy members of the gut; Akkermansia muciniphila, Bacteroides fragilis, Clostridium sordellii, and Clostridium difficile to the Aspirin, this study attempted to provide insight into the effects of the drug on bacterial growth. …
Microbiota Signatures In Type-2 Diabetic Patients With Chronic Kidney Disease - A Pilot Study, Gratiela P. Gradisteanu, Roxana A. Stoica, Laura Petcu, Ariana Picu, Adrian P. Suceveanu, Teodor Salmen, Diana S. Stefan, Cristian Serafinceanu, Mariana Carmen Chifiriuc, Anca P. Stoian
Microbiota Signatures In Type-2 Diabetic Patients With Chronic Kidney Disease - A Pilot Study, Gratiela P. Gradisteanu, Roxana A. Stoica, Laura Petcu, Ariana Picu, Adrian P. Suceveanu, Teodor Salmen, Diana S. Stefan, Cristian Serafinceanu, Mariana Carmen Chifiriuc, Anca P. Stoian
Journal of Mind and Medical Sciences
The human microbiota is paramount for normal host physiology. Altered host-microbiome interactions are part of the pathogenesis of numerous common ailments. Currently, much emphasis is placed on the involvement of the microbiome in the pathogenesis of type-2 diabetes mellitus (T2DM), impaired glucose tolerance, and other metabolic disorders (i.e. obesity). Several studies found highly significant correlations of specific intestinal bacteria with T2DM. A better understanding of the role of the microbiome in diabetes and its complications might provide new insights in the development of new therapeutic principles.
Our pilot study investigates the microbiota patterns in Romanian type-2 diabetic patients with diabetic …